View in EDS

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.

Saved in:
Bibliographic Details
Title: Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.
Authors: Jessen F; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn, Germany; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany., Dell'Agnello G; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: dell_agnello_grazia@lilly.com., Zimmer JA; Eli Lilly and Company, Indianapolis, IN, USA., Sapin C; Eli Lilly and Company, Indianapolis, IN, USA., Dichter S; Eli Lilly and Company, Indianapolis, IN, USA., Doty E; Eli Lilly and Company, Indianapolis, IN, USA., Epelbaum S; Eli Lilly and Company, Indianapolis, IN, USA., Evans CD; Eli Lilly and Company, Indianapolis, IN, USA., Hauck PM; Eli Lilly and Company, Indianapolis, IN, USA., Khanna R; Eli Lilly and Company, Indianapolis, IN, USA., Brooks DA; Eli Lilly and Company, Indianapolis, IN, USA., Sims JR; Eli Lilly and Company, Indianapolis, IN, USA., Agosta F; Unit of Neurology and Neuroimaging of Neurodegenerative Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; 'Vita-Salute San Raffaele' University, Milano, Italy.
Corporate Authors: Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2026 May 27; Vol. 13 (8), pp. 100605. Date of Electronic Publication: 2026 May 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42202469
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jessen+F%22">Jessen F</searchLink>; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn, Germany; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Dell'Agnello+G%22">Dell'Agnello G</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: dell_agnello_grazia@lilly.com.<br /><searchLink fieldCode="AU" term="%22Zimmer+JA%22">Zimmer JA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sapin+C%22">Sapin C</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Dichter+S%22">Dichter S</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Doty+E%22">Doty E</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Epelbaum+S%22">Epelbaum S</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Evans+CD%22">Evans CD</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Hauck+PM%22">Hauck PM</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Khanna+R%22">Khanna R</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+DA%22">Brooks DA</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Sims+JR%22">Sims JR</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Agosta+F%22">Agosta F</searchLink>; Unit of Neurology and Neuroimaging of Neurodegenerative Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; 'Vita-Salute San Raffaele' University, Milano, Italy.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Alzheimer%27s+Disease+Neuroimaging+Initiative+%28ADNI%29%22">Alzheimer’s Disease Neuroimaging Initiative (ADNI)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2026 May 27; Vol. 13 (8), pp. 100605. <i>Date of Electronic Publication: </i>2026 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42202469
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tjpad.2026.100605
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100605
    Titles:
      – TitleFull: Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jessen F
      – PersonEntity:
          Name:
            NameFull: Dell'Agnello G
      – PersonEntity:
          Name:
            NameFull: Zimmer JA
      – PersonEntity:
          Name:
            NameFull: Sapin C
      – PersonEntity:
          Name:
            NameFull: Dichter S
      – PersonEntity:
          Name:
            NameFull: Doty E
      – PersonEntity:
          Name:
            NameFull: Epelbaum S
      – PersonEntity:
          Name:
            NameFull: Evans CD
      – PersonEntity:
          Name:
            NameFull: Hauck PM
      – PersonEntity:
          Name:
            NameFull: Khanna R
      – PersonEntity:
          Name:
            NameFull: Brooks DA
      – PersonEntity:
          Name:
            NameFull: Sims JR
      – PersonEntity:
          Name:
            NameFull: Agosta F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 05
              Text: 2026 May 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2426-0266
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The journal of prevention of Alzheimer's disease
              Type: main
ResultId 1